Clinical Trials Directory

Trials / Completed

CompletedNCT04359251

Different PEEP Settings of COVID-19 Induced ARDS

Avoiding High PEEP in COVID-19 Induced ARDS: a Multi-center Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Southeast University, China · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This was a multi-center prospective study. All consecutive severe cases of COVID-19 whose PO2/FiO2\<300mmHg with invasive ventilation admitted to 5 fixed-point receive COVID-19 patients hospitals in Wuhan from 5 March to 15 March 2020 were included. Epidemiological, clinical data, lung mechanics, artery blood gas test and hemodynamics at three methods to titrate PEEP, optimizing oxygenation, optimizing compliance, ARDSnet. The study was approved by the Ethics Committee of Zhongda Hsopital, Southeast University.

Detailed description

After PEEP titration, PEEP settings could be set by optimizing oxygenation, optimizing compliance, ARDSnet.

Conditions

Interventions

TypeNameDescription
OTHERGas exchanges at different PEEPGas exchanges measurement at different PEEP
OTHERlung mechanics at different PEEPlung mechanics measurement at different PEEP
OTHERHemodynamics changes at different PEEPHemodynamics changes measurement at different PEEP

Timeline

Start date
2020-03-05
Primary completion
2020-03-25
Completion
2020-03-25
First posted
2020-04-24
Last updated
2020-04-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04359251. Inclusion in this directory is not an endorsement.